Micro Interventional Devices, Inc. (MID) is an early stage cardiovascular medical device company founded in May of 2010. MID is developing solutions to unmet needs in structural heart repair procedures, including transcatheter aortic valve implantation (TAVI), transcatheter mitral valve replacement, LVAD placement, mitral valve repair, valvuloplasty, aortic arch repair, ASD and VSD closure, left atrial appendage closure, ablation of arrhythmia and other emerging structural heart repair procedures. Located in Bethlehem, PA, MID is developing proprietary technology based on a breakthrough in soft-tissue anchoring and associated delivery devices that enable off-pump procedures.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/05/12 | $250,000 |
The Life Sciences Greenhouse of Central Pennsylvania | undisclosed | |
| 01/15/13 | $5,000,000 | Series B |
Originate Ventures | undisclosed |
